NCT05417399

Brief Summary

It is the clinical experience of the authors that some children with cerebral palsy who walk in crouch gait show sufficient knee extension during the clinical gait analysis, but walk in considerable knee flexion when they leave the gait laboratory. Possible differences between walking in a gait lab and walking in daily life may be caused by the effect of observational awareness in the lab (also known as the Hawthorne effect), and the lack of dual-tasks (DT) during the analysis (which are common during daily life walking). Since so far there is no technique to reliably measure gait kinematics in children with CP outside of the laboratory, the researchers aim to objectify the influence of both the Hawthorne effect and dual-tasks by introducing different conditions during a standard clinical 3D gait analysis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
28mo left

Started Sep 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2022Dec 2028

First Submitted

Initial submission to the registry

June 9, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 14, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

July 13, 2026

Status Verified

July 1, 2026

Enrollment Period

5.3 years

First QC Date

June 9, 2022

Last Update Submit

July 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Minimal knee flexion during the single support phase

    Minimal knee flexion during the single support phase

    Day 1

Secondary Outcomes (8)

  • Foot to floor angle at initial contact

    Day 1

  • Knee flexion at initial contact

    Day 1

  • Foot to floor angle at moment of minimal knee flexion in single support phase

    Day 1

  • Variation of knee kinematics in stance phase

    Day 1

  • Variation of ankle kinematics in stance phase

    Day 1

  • +3 more secondary outcomes

Eligibility Criteria

Age4 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All subjects are recruited from the patient base of Roessingh Center for Rehabilitation. Subjects will be included in the study when a clinical 3D gait analysis is due and the inclusion and exclusion criteria as mentioned are met.

You may qualify if:

  • Cerebral palsy, bilateral spastic, GMFCS classification I-III
  • Age \<16 years
  • Use of bilateral AFO's (rigid or ground reaction AFO's) to improve knee extension in stance

You may not qualify if:

  • Behavioural issues or poor instructability which might affect participation in the protocol
  • Significant visual disorders
  • Other diagnoses influencing gait

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roessingh Research and Development

Enschede, Overijssel, 7522AH, Netherlands

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hans Rietman, Professor

    Roessingh Research and Development

    STUDY CHAIR

Central Study Contacts

Martin Oude Alink, Msc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2022

First Posted

June 14, 2022

Study Start

September 1, 2022

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

July 13, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations